Yongquan Shi

National Key Laboratory Of Immunity And Inflammation
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Metabolically and epigenetically reprogrammed splenic TRNP1hiCD8+ T cells exacerbate liver fibrosis.

Metabolically and epigenetically reprogrammed splenic TRNP1hiCD8+ T cells exacerbate liver fibrosis.

Journal: Nature genetics

Published: August 19, 2025

Atrial fibrillation: an underappreciated complication of diabetes.

Atrial fibrillation: an underappreciated complication of diabetes.

Journal: European heart journal

Published: June 10, 2025

Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic β-cell function pretransplant.

Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic β-cell function pretransplant.

Journal: The lancet. Diabetes & endocrinology

Published: March 10, 2025

Can chimeric antigen receptors - based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?

Can chimeric antigen receptors - based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?

Journal: Medical review (2021)

Published: December 18, 2024

Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial.

Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial.

Journal: BMJ (Clinical research ed.)

Published: October 15, 2024

S100A9 as a promising therapeutic target for diabetic foot ulcers.

S100A9 as a promising therapeutic target for diabetic foot ulcers.

Journal: Chinese medical journal

Published: September 28, 2024

Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue.

Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue.

Journal: Cell discovery

Published: October 23, 2023

Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus.

Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus.

Journal: Diabetes research and clinical practice

Published: September 08, 2022

Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges.

Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 04, 2022

Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.

Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.

Journal: Current medical research and opinion

Published: July 14, 2022

MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy.

MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy.

Journal: Journal of inflammation research

Published: September 22, 2021

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.

Journal: Nature medicine

Published: July 19, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026